RGNT

Regentis Biomaterials Ltd

3.000

0.0000.00%

Closed10:42 04/28 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.713/2.910

TODAY RANGE2.700-2.880

VOL17.66K

MARKET CAP14.86M

52 WEEK RANGE2.700-8.35

AVG VOL (3M)6.39K

% TURNOVER0.34%

TURNOVER--

P/E (TTM)-0.1192

% RANGE6.19%

EPS(TTM)-24.0816

P/E(FORWARD)--

P/B3.134

BVPS0.9159

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.59M

SHARES OUTSTANDING5.18M

NEXT EARNINGS--

FREE FLOAT1.25M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·04/16 12:51
Regentis Biomaterials enters collaboration with Humanitas Research Hospital
TipRanks·03/17 13:07
Regentis Biomaterials develops and patents solvent-free manufacturing process
TipRanks·03/02 11:39
Regentis Biomaterials initiated with a Buy at ThinkEquity
TipRanks·02/24 22:00
Regentis Biomaterials Posts 2025 Results, Advances GelrinC Toward Phase III Milestones and 2026 EU Rollout
Seeking Alpha·02/24 21:39
Regentis Biomaterials Ltd. reports FY results
TipRanks·02/19 13:57
Regentis Biomaterials appoints Galit Reke as CMO
TipRanks·02/17 14:57
Regentis Biomaterials Expands European Clinical Network Ahead of 2026 GelrinC Launch
TipRanks·02/17 13:45
Regentis Biomaterials expands European clinical site network
TipRanks·02/05 11:57
Regentis Biomaterials Taps New CFO/Chief Business Officer as GelrinC Nears EU Launch and Midpoint of U.S. Phase III Trial
TipRanks·02/04 14:01
Regentis Biomaterials appoints Ori Gon as CFO, CBO
Seeking Alpha·02/04 13:56
Regentis Biomaterials appoints new CFO
TipRanks·01/29 14:41
Regentis Biomaterials Expands U.S. Phase III GelrinC Trial Network After Enrollment Surpasses Midpoint
TipRanks·01/29 13:50
Regentis Biomaterials expanding Phase III GelrinC clinical site network
TipRanks·01/28 16:25
Regentis Biomaterials Ltd trading resumes
TipRanks·01/20 14:38
Regentis’ GelrinC Shows Native-Like Cartilage Regeneration in 2-Year MRI Data

Same Industry

Name/Symbol

Change%

Price

Regeneron Pharmaceuticals

REGN

-0.96%

744.37

GridAI Tech

GRDX

0.00%

2.270

BIONTECH

BNTX

-0.09%

105.46

United Therapeutics Corp.

UTHR

-0.99%

567.16

Vertex Pharmaceuticals Inc

VRTX

-1.11%

430.29

Siga Technologie

SIGA

+0.88%

4.570

Moderna

MRNA

-4.01%

50.73

CRL

Medpace Holdings

MEDP

-0.27%

417.54

TLPH

ICLR

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+1.00%

162.28

MOLECULAR PARTNERS AG

MOLN

+3.97%

4.450

ARCT

Gilead Sciences Inc

GILD

+1.18%

129.26

PRAH

Incyte Corp

INCY

-0.86%

94.65

Aptevo Therapeutics Inc

APVO

-0.31%

4.870

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.